|
Results from Part I of ISMP Survey on Pharmacy InterventionsFrom the June 26, 2002 issue Factors that facilitate the pharmacist's ability to perform interventions1 = NOT Present in facility 5 = Present in facility All Responses N=608
Hospitals with (W) Pharmacy Residency Programs N=119; Hospitals without (WO) N=489 Percentage of Respondents
Hospitals with (W) Physician Residency Programs N=236; Hospitals without (WO) N=372 Percentage of Respondents
Hospital Type General Hospital (G) N=461; Specialty Hospital (S) N=68 Percentage of Respondents
Effectiveness of factors related to pharmacist's ability to perform interventionsFactors that facilitate the pharmacist's ability to perform interventions
Part II - Types
of Pharmacy Intervention Services Provided by Hospitals
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Intervention Categories | Not Performed | Routine Activities | Targeted Activities |
| a) antimicrobial therapy |
16 |
50 |
31 |
| b) anticoagulation therapy |
40 |
30 |
28 |
|
c) narcotics/pain management |
42 |
30 |
26 |
|
d) drug dose verification |
4 |
86 |
9 |
|
e)appropriateness of drug
selection |
15 |
66 |
15 |
|
f) renal dosing |
15 |
53 |
30 |
|
g) monitor special populations
(pediatrics, oncology, elderly) |
20 |
48 |
29 |
|
h) detect patient allergies
related to prescribed therapy |
2 |
87 |
9 |
|
i) verify order completeness |
2 |
89 |
7 |
|
j) identify dangerous abbreviations,
dose expressions |
13 |
69 |
16 |
Hospitals
with (W) Pharmacy Residency Programs N=119; Hospitals
without (WO) N= 489 Percentage of Respondents
Intervention Categories |
Not Performed |
Routine Activities |
Targeted Activities |
|||
| W | WO | W | WO | W | WO | |
|
a) antimicrobial therapy |
12 |
17 |
41 |
53 |
45 |
28 |
|
b) anticoagulation therapy |
20 |
45 |
34 |
29 |
45 |
24 |
|
c) narcotics/pain management |
28 |
46 |
31 |
30 |
40 |
22 |
|
d) drug dose verification |
1 |
4 |
83 |
86 |
15 |
7 |
|
e)appropriateness of drug
selection |
8 |
17 |
69 |
66 |
22 |
14 |
|
f) renal dosing |
13 |
15 |
44 |
55 |
42 |
27 |
|
g) monitor special populations
(pediatrics, oncology, elderly) |
12 |
22 |
45 |
49 |
43 |
25 |
|
h) detect patient allergies
related to prescribed therapy |
2 |
3 |
86 |
87 |
13 |
8 |
|
i) verify order completeness |
3 |
1 |
86 |
90 |
10 |
6 |
|
j) identify dangerous abbreviations,
dose expressions |
12 |
13 |
73 |
68 |
15 |
16 |
Hospitals
with (W) Physician Residency Programs N=236;
Hospitals without
(WO) N=372 Percentage of Respondents
Intervention Categories
|
Not Performed |
Routine Activities |
Targeted Activities |
|||
| W | WO | W | WO | W | WO | |
|
a) antimicrobial therapy |
15 |
17 |
44 |
54 |
40 |
26 |
|
b) anticoagulation therapy |
33 |
44 |
30 |
30 |
36 |
23 |
|
c) narcotics/pain management |
43 |
42 |
31 |
29 |
25 |
26 |
|
d) drug dose verification |
3 |
4 |
87 |
85 |
9 |
8 |
|
e)appropriateness of drug
selection |
12 |
17 |
71 |
64 |
15 |
16 |
|
f) renal dosing |
14 |
15 |
51 |
54 |
35 |
27 |
|
g) monitor special populations
(pediatrics, oncology, elderly) |
17 |
23 |
48 |
48 |
34 |
25 |
|
h) detect patient allergies
related to prescribed therapy |
3 |
2 |
87 |
86 |
10 |
9 |
|
i) verify order completeness |
1 |
2 |
90 |
88 |
8 |
6 |
|
j) identify dangerous abbreviations,
dose expressions |
11 |
15 |
74 |
66 |
15 |
17 |
Hospital Type General Hospital (G) N=461;
Specialty Hospital (S)
N=68
Percentage of Respondents
Intervention Categories
|
Not Performed |
Routine Activities |
Targeted Activities |
|||
| G | S | G | S | G | S | |
|
a) antimicrobial therapy |
12 |
21 |
52 |
50 |
35 |
26 |
|
b) anticoagulation therapy |
39 |
41 |
30 |
34 |
30 |
21 |
|
c) narcotics/pain management |
44 |
40 |
28 |
34 |
26 |
24 |
|
d) drug dose verification |
3 |
4 |
88 |
81 |
8 |
12 |
|
e)appropriateness of drug
selection |
15 |
16 |
67 |
71 |
16 |
12 |
|
f) renal dosing |
8 |
25 |
57 |
49 |
34 |
24 |
|
g) monitor special populations
(pediatrics, oncology, elderly) |
19 |
16 |
48 |
62 |
31 |
21 |
|
h) detect patient allergies
related to prescribed therapy |
2 |
0 |
88 |
88 |
9 |
10 |
|
i) verify order completeness |
2 |
0 |
91 |
87 |
7 |
10 |
|
j) identify dangerous abbreviations,
dose expressions |
13 |
6 |
68 |
81 |
18 |
12 |
Bed Size Up to 299 Beds Percentage of
Respondents
Intervention Categories
|
Not Performed |
Routine Activities |
Targeted Activities |
|||
| <100 | 100-299 | <100 | 100-299 | <100 | 100-299 | |
|
a) antimicrobial therapy |
20 |
12 |
58 |
50 |
22 |
36 |
|
b) anticoagulation therapy |
49 |
43 |
28 |
28 |
22 |
28 |
|
c) narcotics/pain management |
40 |
47 |
34 |
26 |
25 |
25 |
|
d) drug dose verification |
6 |
2 |
85 |
88 |
8 |
8 |
|
e)appropriateness of drug
selection |
17 |
16 |
67 |
67 |
13 |
16 |
|
f) renal dosing |
19 |
11 |
58 |
55 |
22 |
33 |
|
g) monitor special populations
(pediatrics, oncology, elderly) |
25 |
17 |
54 |
51 |
20 |
30 |
|
h) detect patient allergies
related to prescribed therapy |
1 |
3 |
92 |
88 |
7 |
9 |
|
i) verify order completeness |
1 |
2 |
94 |
89 |
4 |
8 |
|
j) identify dangerous abbreviations,
dose expressions |
14 |
13 |
70 |
72 |
15 |
15 |
Bed Size 300 to >500 beds Percentage of Respondents
Intervention Categories
|
Not Performed |
Routine Activities |
Targeted Activities |
|||
| 300-499 | >=500 | 300-499 | >=500 | 300-499 | >=500 | |
|
a) antimicrobial therapy |
10 |
17 |
46 |
47 |
40 |
36 |
|
b) anticoagulation therapy |
30 |
26 |
36 |
32 |
31 |
42 |
|
c) narcotics/pain management |
30 |
38 |
46 |
39 |
17 |
23 |
|
d) drug dose verification |
0 |
1 |
89 |
88 |
9 |
10 |
|
e)appropriateness of drug
selection |
9 |
14 |
69 |
65 |
20 |
18 |
|
f) renal dosing |
7 |
12 |
48 |
55 |
42 |
32 |
|
g) monitor special populations
(pediatrics, oncology, elderly) |
20 |
14 |
41 |
43 |
35 |
40 |
|
h) detect patient allergies
related to prescribed therapy |
2 |
4 |
87 |
81 |
9 |
16 |
|
i) verify order completeness |
0 |
1 |
89 |
90 |
7 |
9 |
|
j) identify dangerous abbreviations,
dose expressions |
9 |
12 |
68 |
69 |
21 |
18 |
Part II - Communication of Interventions and Use to Improve the Prescribing Process ns
Questions |
Percentage of respondents |
|||||||||
|
|
|
|
300-499 beds |
Over 500 beds |
||||||
|
Yes |
No |
Yes |
No |
Yes |
No |
Yes |
No |
Yes |
No |
|
|
a)
As a whole, does the medical staff respond well to
pharmacists' interventions? |
94 |
6 |
96 |
4 |
94 |
4 |
94 |
6 |
94 |
6 |
|
b)
Are pharmacy interventions included as a measure of
performance in evaluating all pharmacists (clinical
and dispensing)? |
47 |
53 |
36 |
64 |
56 |
44 |
49 |
51 |
55 |
45 |
|
c)
Are pharmacy interventions routinely documented? |
78 |
22 |
69 |
31 |
85 |
15 |
83 |
17 |
82 |
18 |
|
d)
Are factors related to the prescribing errors identified
by pharmacists presented to committees/staff for the
purpose of improving the prescribing process? |
64 |
36 |
51 |
49 |
74 |
26 |
73 |
27 |
68 |
32 |
|
e)
Is the documentation of pharmacy interventions detailed
enough to guide improvement? |
61 |
39 |
52 |
48 |
70 |
30 |
60 |
40 |
62 |
38 |
|
f)
In the past year, have pharmacy interventions been
used to plan and carry out medical staff education? |
44 |
56 |
35 |
65 |
48 |
52 |
53 |
47 |
53 |
47 |
|
g)
Excluding prescriber education, have pharmacy interventions
been used in the past year to improve the prescribing
process (establish guidelines, protocols, standardized
order sets, etc.)? |
63 | 38 |
52 |
48 |
70 |
30 |
69 |
31 |
68 |
32 |
|
Questions |
Percentage of respondents |
|||||||
|
With Pharmacy Residency |
Without |
With |
Without Physician Residency |
|||||
|
Yes |
No |
Yes |
No |
Yes |
No |
Yes |
No |
|
|
a)
As a whole, does the medical staff respond well to
pharmacists' interventions? |
97 |
3 |
93 |
7 |
96 |
4 |
93 |
7 |
|
b)
Are pharmacy interventions included as a measure of
performance in evaluating all pharmacists (clinical
and dispensing)? |
55 |
45 |
45 |
55 |
53 |
47 |
44 |
56 |
|
c)
Are pharmacy interventions routinely documented? |
77 |
23 |
78 |
22 |
80 |
20 |
76 |
24 |
|
d)
Are factors related to the prescribing errors identified
by pharmacists presented to committees/staff for the
purpose of improving the prescribing process? |
65 |
35 |
64 |
36 |
69 |
31 |
61 |
39 |
|
e)
Is the documentation of pharmacy interventions detailed
enough to guide improvement? |
59 |
41 |
61 |
39 |
64 |
36 |
59 |
41 |
|
f)
In the past year, have pharmacy interventions been
used to plan and carry out medical staff education? |
48 |
52 |
44 |
56 |
50 |
50 |
41 |
59 |
|
g)
Excluding prescriber education, have pharmacy interventions
been used in the past year to improve the prescribing
process (establish guidelines, protocols, standardized
order sets, etc.)? |
65 |
35 |
62 |
38 |
69 |
31 |
59 |
41 |
Copyright © 2012, ISMP. All rights reserved |